250 related articles for article (PubMed ID: 19536138)
1. A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.
Mao Y; Balkin DM; Zoncu R; Erdmann KS; Tomasini L; Hu F; Jin MM; Hodsdon ME; De Camilli P
EMBO J; 2009 Jul; 28(13):1831-42. PubMed ID: 19536138
[TBL] [Abstract][Full Text] [Related]
2. A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway.
Erdmann KS; Mao Y; McCrea HJ; Zoncu R; Lee S; Paradise S; Modregger J; Biemesderfer D; Toomre D; De Camilli P
Dev Cell; 2007 Sep; 13(3):377-90. PubMed ID: 17765681
[TBL] [Abstract][Full Text] [Related]
3. A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells.
Nández R; Balkin DM; Messa M; Liang L; Paradise S; Czapla H; Hein MY; Duncan JS; Mann M; De Camilli P
Elife; 2014 Aug; 3():e02975. PubMed ID: 25107275
[TBL] [Abstract][Full Text] [Related]
4. The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin.
Ungewickell A; Ward ME; Ungewickell E; Majerus PW
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13501-6. PubMed ID: 15353600
[TBL] [Abstract][Full Text] [Related]
5. Recognition of the F&H motif by the Lowe syndrome protein OCRL.
Pirruccello M; Swan LE; Folta-Stogniew E; De Camilli P
Nat Struct Mol Biol; 2011 Jun; 18(7):789-95. PubMed ID: 21666675
[TBL] [Abstract][Full Text] [Related]
6. Rab35 GTPase Triggers Switch-like Recruitment of the Lowe Syndrome Lipid Phosphatase OCRL on Newborn Endosomes.
Cauvin C; Rosendale M; Gupta-Rossi N; Rocancourt M; Larraufie P; Salomon R; Perrais D; Echard A
Curr Biol; 2016 Jan; 26(1):120-8. PubMed ID: 26725203
[TBL] [Abstract][Full Text] [Related]
7. Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome.
Bothwell SP; Farber LW; Hoagland A; Nussbaum RL
Mamm Genome; 2010 Oct; 21(9-10):458-66. PubMed ID: 20872266
[TBL] [Abstract][Full Text] [Related]
8. Kidney Tubular Ablation of
Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S
J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154
[TBL] [Abstract][Full Text] [Related]
9. Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1.
Swan LE; Tomasini L; Pirruccello M; Lunardi J; De Camilli P
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3511-6. PubMed ID: 20133602
[TBL] [Abstract][Full Text] [Related]
10. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
[TBL] [Abstract][Full Text] [Related]
11. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
[TBL] [Abstract][Full Text] [Related]
12. Targeting of the type II inositol polyphosphate 5-phosphatase INPP5B to the early secretory pathway.
Williams C; Choudhury R; McKenzie E; Lowe M
J Cell Sci; 2007 Nov; 120(Pt 22):3941-51. PubMed ID: 17956944
[TBL] [Abstract][Full Text] [Related]
13. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
De Matteis MA; Staiano L; Emma F; Devuyst O
Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
[TBL] [Abstract][Full Text] [Related]
14. The role of the Lowe syndrome protein OCRL in the endocytic pathway.
Sharma S; Skowronek A; Erdmann KS
Biol Chem; 2015 Dec; 396(12):1293-300. PubMed ID: 26351914
[TBL] [Abstract][Full Text] [Related]
15. A novel all helix fold of the AP180 amino-terminal domain for phosphoinositide binding and clathrin assembly in synaptic vesicle endocytosis.
Mao Y; Chen J; Maynard JA; Zhang B; Quiocho FA
Cell; 2001 Feb; 104(3):433-40. PubMed ID: 11239400
[TBL] [Abstract][Full Text] [Related]
16. All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding.
McCrea HJ; Paradise S; Tomasini L; Addis M; Melis MA; De Matteis MA; De Camilli P
Biochem Biophys Res Commun; 2008 May; 369(2):493-9. PubMed ID: 18307981
[TBL] [Abstract][Full Text] [Related]
17. Compensatory Role of Inositol 5-Phosphatase INPP5B to OCRL in Primary Cilia Formation in Oculocerebrorenal Syndrome of Lowe.
Luo N; Kumar A; Conwell M; Weinreb RN; Anderson R; Sun Y
PLoS One; 2013; 8(6):e66727. PubMed ID: 23805271
[TBL] [Abstract][Full Text] [Related]
18. Optogenetic control of phosphoinositide metabolism.
Idevall-Hagren O; Dickson EJ; Hille B; Toomre DK; De Camilli P
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):E2316-23. PubMed ID: 22847441
[TBL] [Abstract][Full Text] [Related]
19. A functional phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain in the clathrin adaptor AP-2 alpha subunit. Implications for the endocytic pathway.
Gaidarov I; Chen Q; Falck JR; Reddy KK; Keen JH
J Biol Chem; 1996 Aug; 271(34):20922-9. PubMed ID: 8702850
[TBL] [Abstract][Full Text] [Related]
20. Multi-modal adaptor-clathrin contacts drive coated vesicle assembly.
Smith SM; Larocque G; Wood KM; Morris KL; Roseman AM; Sessions RB; Royle SJ; Smith CJ
EMBO J; 2021 Oct; 40(19):e108795. PubMed ID: 34487371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
